Pharma Could Do Better With Data, Say IBM, McLaren
The great and good of the pharmaceutical industry have again been speaking about the big opportunities that big data provides, but senior executives from IBM Watson Health and Formula 1 giant McLaren believe the sector should be doing more.
You may also be interested in...
Big data may be prolonging development times for new pharmaceuticals, as companies struggle to cope with diverse digital applications and clinical trial protocol changes.
Urgent calls for industry to generate and apply real world evidence were matched at a recent conference only by complaints about challenges faced by this growing, ill-defined evidence category.
By adding another AI deal to Sanofi's innovation quiver, the French group says it's widening its hunt to find single molecules that offer dual or multi-specific targeting to fight disease.